[ad_1]
BERLIN – The German chemical and pharmaceutical company Bayer has announced its intention to invest about 5 billion euros over the next decade in the development of "additional methods of weed control".
Friday's announcement came as Bayer was engaged in legal battles in the United States in which plaintiffs claim that Monsanto's Roundup weed killer caused the cancer. Decisions in three cases go against that.
Bayer claims that studies have established that glyphosate, the active ingredient in Roundup, is safe and made it clear on Friday that it was product compliant. A company statement said, "Although glyphosate continues to play an important role in Bayer's agriculture and portfolio, the company is committed to offering more choice to producers."
Bayer acquired Monsanto for $ 63 billion last year.
Copyright 2019 The Associated Press. All rights reserved. This material may not be published, disseminated, rewritten or redistributed.
Source link
